Inbrija Interactions
There are 518 drugs known to interact with Inbrija (levodopa), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 457 are moderate, and 11 are minor.
- View all 518 medications that may interact with Inbrija
- View Inbrija alcohol/food interactions (1)
- View Inbrija disease interactions (11)
Most frequently checked interactions
View interaction reports for Inbrija (levodopa) and the medicines listed below.
- amantadine
- amantadine
- aspirin
- aspirin
- carbidopa / levodopa
- carbidopa / levodopa
- clonazepam
- clonazepam
- gabapentin
- gabapentin
- levothyroxine
- levothyroxine
- melatonin
- melatonin
- Myrbetriq (mirabegron)
- Myrbetriq (mirabegron)
- omeprazole
- omeprazole
- ropinirole
- ropinirole
- Rytary (carbidopa / levodopa)
- Rytary (carbidopa / levodopa)
- Sinemet (carbidopa / levodopa)
- Sinemet (carbidopa / levodopa)
- trazodone
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Inbrija alcohol/food interactions
There is 1 alcohol/food interaction with Inbrija (levodopa).
Inbrija disease interactions
There are 11 disease interactions with Inbrija (levodopa) which include:
- cardiac disease
- neuroleptic malignant syndrome
- psychoses/depression
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- sleep disorders
- hypotension
- psychosis
- GI bleeding
Report options
More about Inbrija (levodopa)
- Inbrija consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Gocovri
Gocovri (amantadine) is used in the treatment of Parkinson's disease. Includes Gocovri side ...
Rivastigmine
Rivastigmine systemic is used for alzheimer's disease, lewy body dementia, parkinson's disease
Amantadine
Easy-to-read patient leaflet for amantadine. Includes indications, proper use, special ...
Carbidopa/levodopa
Carbidopa/levodopa systemic is used for GTP-CH Deficiency, neuroleptic malignant syndrome ...
Benztropine
Benztropine systemic is used for extrapyramidal reaction, hyperhidrosis, parkinson's disease
Pramipexole
Pramipexole systemic is used for parkinson's disease, periodic limb movement disorder, restless ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
